Region-and age-specific changes in glutamate transport in the AβPP23 mouse model for alzheimer's disease

Journal of Alzheimer's Disease

Volumn 24, Issue 2, 2011, Pages 287-300

  Schallier, Anneleen ^a   Smolders, Ilse ^a   Van Dam, Debby ^b   Loyens, Ellen ^a   De Deyn, Peter Paul ^b,c   Michotte, Alex ^d   Michotte, Yvette ^a   Massie, Ann ^a  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c MIDDELHEIM HOSPITAL   (Belgium)

^d UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Alzheimer's disease; A PP23 model; cortex; EAAT; hippocampus; VGLUT; xCT

Indexed keywords

AMYLOID PRECURSOR PROTEIN; EXCITATORY AMINO ACID TRANSPORTER; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; SODIUM GLUCOSE COTRANSPORTER 1; UNCLASSIFIED DRUG; XCT PROTEIN;

AGE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EPILEPTIC STATE; EXTRACELLULAR SPACE; HIPPOCAMPUS; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; UPREGULATION; WILD TYPE;

EID: 79955574336     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2011-101005     Document Type: Article

References (60)

1. Walton HS, Dodd PR (2007) Glutamate-glutamine cycling in Alzheimer's disease. Neurochem Int 50, 1052-1066. (Pubitemid 46962807)
2. Lipton SA (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev 5, 160-170.
3. Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97, 1634-1658. (Pubitemid 43873658)
4. Beart PM, O'Shea RD (2007) Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150, 5-17. (Pubitemid 46094664)
5. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65, 1-105. (Pubitemid 32479155)
6. Aoyama K, Suh SW, Hamby AM, Liu J, Chan WY, Chen Y, Swanson RA (2006) Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci 9, 119-126. (Pubitemid 43011917)
7. Duerson K, Woltjer RL, Mookherjee P, Leverenz JB, Montine TJ, Bird TD, Pow DV, Rauen T, Cook DG (2009) Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients. Brain Pathol 19, 267-278.
8. Takamori S (2006) VGLUTs: 'exciting' times for glutamater-gic research? Neurosci Res 55, 343-351.
9. Fremeau RT, Burman J, Qureshi T, Tran CH, Proctor J, Johnson J, Zhang H, Sulzer D, Copenhagen DR, Storm-Mathisen J, Reimer RJ, Chaudhry FA, Edwards RH (2002) The identification of vesicular glutamate transporter 3 sug-gests novel modes of signaling by glutamate. Proc Natl Acad Sci USA99, 14488-14493. (Pubitemid 35257698)
10. Wilson NR, Kang J, Hueske EV, Leung T, Varoqui H, Murnick JG, Erickson JD, Liu G (2005) Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J Neurosci 25, 6221-6234. (Pubitemid 40923489)
11. Sato H, Tamba M, Ishii T, Bannai S (1999) Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. JBiol Chem 247, 37423-37439.
12. Bannai S (1986) Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem 261, 2256-2263. (Pubitemid 17205155)
13. Baker DA, Xi ZX, Shen H, Swanson CJ, Kalivas PW (2002) The origin and neuronal function of in vivo nonsynaptic glu-tamate. JNeurosci 22, 9134-9141. (Pubitemid 35379084)
14. c~ deficient mice are highly protected against 6-hydroxydopamine-induced toxicity. FASEB J 25, 1-11.
15. Scott HL, Tannenberg AE, Dodd PR (1995) Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J Neurochem 64, 2193-2202.
16. Li S, Mallory M, Alford M, TanakaS, MasliahE (1997) Gluta-mate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 56, 901-911. (Pubitemid 27329111)
17. Beckstrøm H, Julsrud L, Haugeto O, Dewar D, Graham DI, Lehre KP, Storm-Mathisen J, Danbolt NC (1999) Interindi-vidual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer's disease. J Neurosci Res 55, 218-229. (Pubitemid 29056962)
18. Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR, Butterfield DA (2001) The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem 78, 413-416. (Pubitemid 32664423)
19. Dodd PR (2002) Excited to death: different ways to lose your neurones. Biogerontology 3, 51-56. (Pubitemid 34284977)
20. Jacob CP, Koutsilieri E, Bartl J, Neuen-Jacob E, Arzberger T, Zander N, Ravid R, Roggendorf W, Riederer P, Grünblatt E (2007) Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease. J Alzheimers Dis 11, 97-116. (Pubitemid 46376714)
21. Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, Savva G, Brayne C, Wharton SB (2010) Astrocyte phe-notype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging 31, 578-590.
22. Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 40, 759-766. (Pubitemid 26415188)
23. Masliah E, Alford M, Mallory M, Rockenstein E, Moechars D, Van Leuven F (2000) Abnormal glutamate transport func-tion in mutant amyloid precursor protein transgenic mice. Exp Neurol 163, 381-387. (Pubitemid 30399086)
24. Malm TM, Iivonen H, Goldsteins G, Keksa-Goldsteine V, Ahtoniemi T, Kanninen K, Salminen A, Auriola S, Van Groen T, Tanila H, Koistinaho J (2007) Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden. J Neurosci 27, 3712-3721. (Pubitemid 46557689)
25. Minkeviciene R, Ihalainen J, Malm T, Matilainen O, Keksa-Goldsteine V, Goldsteins G, Iivonen H, Leguit N, Glennon J, Koistinaho J, Banerjee P, Tanila H (2008) Age-related decrease in stimulated glutamate release and vesicular gluta-mate transporters in APP/PS1 transgenic and wild-type mice. J Neurochem 105, 584-594. (Pubitemid 351562711)
26. Kashani A, Lepicard E, Poirel O, Videau C, David JP, Fallet-Bianco C, Simon A, Delacourte A, Giros B, Epelbaum J, Betancur C, El Mestikawy S (2008) Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease. Neurobiol Aging 29, 1619-1630.
27. Kirvell SL, Esiri M, Francis PT (2006) Down-regulation of vesicular glutamate transporters precedes cell loss and pathol-ogy in Alzheimer's disease. J Neurochem 98, 939-950. (Pubitemid 44051293)
28. Qin S, Colin C, Hinners I, Gervais A, Cheret C, Mallat M (2006) System Xc-and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. JNeurosci 26, 3345-3356.
29. Van Dam D, Vloeberghs E, Abramowski D, Staufenbiel M, De Deyn PP (2005) APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder. CNS Spectr 10, 207-222. (Pubitemid 40489290)
30. Van Dam D, De Deyn PP (2006) Drug discovery in dementia: the role of rodent models. Nat Rev Drug Discov 5, 956-970. (Pubitemid 44660608)
31. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Bürki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B (1997) Two amyloid precursor pro-tein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94, 13287-13292. (Pubitemid 27518514)
32. Yamada K, Watanabe M, Shibata T, Nagashima M, Tanaka K, Inoue Y (1998) Glutamate transporter GLT-1 is transiently localized on growing axons of the mouse spinal cord before establishing astrocytic expression. JNeurosci 18, 5706-5713. (Pubitemid 28341350)
33. Shibata T, Yamada K, Watanabe M, Ikenaka K, Wada K, Tanaka K, Inoue Y (1997) Glutamate transporter GLAST is expressed in the radial glia-astrocyte lineage of developing mouse spinal cord. J Neurosci 17, 9212-9219. (Pubitemid 27498449)
34. Shu S, Ju G, Fan L (1988) The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 84, 169-171. (Pubitemid 18048772)
35. Massie A, Cnops L, Jacobs S, Van DammeK, Vandenbussche E, Eysel UT, Vandesande F, Arckens L (2003) Glutamate lev-els and transport in cat (Felis catus) area 17 during cortical reorganization following binocular retinal lesions. J Neu-rochem84, 1387-1397. (Pubitemid 36343605)
36. Massie A, Schallier A, Mertens B, Vermoesen K, Bannai S, Sato H, Smolders I, Michotte Y (2008) Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats.NeuroReport19, 1589-1592.
37. Racine RJ (1972) Modification of seizure activity by electri-cal stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32, 281-294.
38. Smolders I, Sarre S, Michotte Y, Ebinger G (1995) The analy-sis of excitatory, inhibitory and other amino acids in rat brain microdialysates using microbore liquid chromatography. J Neurosci Methods 57, 47-53.
39. Robinson MB (2006) Acute regulation of sodium-dependent glutamate transporters: a focus on constitutive and regulated trafficking. Handbook Exp Pharmacol 175, 251-275.
40. Bell KF, de Kort GJ, Steggerda S, Shigemoto R, Ribeiro-da-Silva A, Cuello AC (2003) Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology. Neurosci Lett 353, 143-147. (Pubitemid 37510201)
41. Lehre KP, Danbolt NC(1998)The number of glutamate trans-porter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J Neurosci 18, 8751-8757. (Pubitemid 28491741)
42. Shimamoto K, Sakai R, Takaoka K, Yumoto N, Nakajima T, Amara SG, Shigeri Y (2004) Characterization of novel L-threo-ß-benzylaspartate derivates, potent blockers of glu-tamate transporters. Mol Pharmacol 65, 1008-1015. (Pubitemid 38420507)
43. Boncristiano S, Calhoun ME, Howard V, Bondolfi L, Kaeser SA, Wiederhold KH, Staufenbiel M, Jucker M (2005) Neo-cortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice. Neurobiol Aging 26, 607-613. (Pubitemid 40228752)
44. Goedert M (1993) Tau protein and the neurofibrillary pathol-ogy of Alzheimer's disease. TrendsNeurosci 16, 460-465. (Pubitemid 23313524)
45. Lewerenz J, Maher P (2009) Basal levels of elF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. JBiol Chem 284, 1106-1115.
46. Lowe SL, Bowen DM (1990) Glutamic acid concentration in brains of patients with Alzheimer's disease. Biochem Soc Traps 18, 443-444. (Pubitemid 20181079)
47. Smith CCT, Bowen DM, Neary D, Davison AN (1983) Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease. Brain Res 264, 138-141. (Pubitemid 13111239)
48. Procter AW, Lowe SL, Palmer AM, Francis PT, Esiri MM, Stratmann GC, Najlerahin A, Patel AJ, Hunt A, Bower DM (1988) Topographical distribution of neurochemical changes in Alzheimer's disease. J Neurol Sci 84, 125-140. (Pubitemid 18087256)
49. Van Dam D, Marescau B, Cremers T, Mulder J, Engelborghs S, De Deyn PP (2005) Regional distribution of biogenic amines, amino acids and cholinergic markers in the CNS of the C57BL/6 strain. Amino Acids 28, 377-387. (Pubitemid 40884728)
50. (1)H-MRS at 0.5 T Neurology 56, 737-742. (Pubitemid 32240092)
51. Torp R, Lekieffre D, Levy LM, Haug FM, Danbolt NC, Meldrum BS, Ottersen OP (1995) Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus. Exp Brain Res 103, 51-58.
52. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss ofglial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38, 73-84.
53. 2+ homeostasis in Alzheimer's disease. Trends Neurosci 16, 409-414. (Pubitemid 23283402)
54. Ikegaya Y, Matsuura S, Ueno S, Baba A, Yamada MK, Nishiyama N, Matsuki N (2002) Beta-amyloid enhances glial glutamate uptake activity and attenuates synaptic efficacy. J Biol Chem 35, 32180-32186. (Pubitemid 34969032)
55. Abe K, Misawa M (2003) The extracellular signal-regulated kinase cascade suppresses amyloid beta protein-induced promotion of glutamate clearance in cultured rat cortical astrocytes. Brain Res 979, 179-187. (Pubitemid 36792168)
56. Ondrejcak T, Klyubin I, Hu NW, Barry AE, Cullen WK, Rowan MJ (2010) Alzheimer's disease amyloid beta-protein and synaptic function. Neuromolecular Med 12, 13-26.
57. Mattson MP (2007) Calcium and neurodegeneration. Aging Cell 6, 337-350.
58. Masliah E, Raber J, Alford M, Mallory M, Mattson MP, Yang D, Wong D, Mucke L (1998) Amyloid protein precursor stimulates excitatory amino acid transport. Implications for roles in neuroprotection and pathogenesis. J Biol Chem 273, 12548-12554. (Pubitemid 28240630)
59. Harkany T, Abrahám I, Timmerman W, Laskay G, Tóth B, Sasvári M, Kónya C, Sebens JB, Korf J, Nyakas C, Zarándi M, Soós K, Penke B, Luiten PG (2000) Beta-amyloid neu-rotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci 12, 2735-2745.
60. Bornemann KD, Wiederhold KH, Pauli C, Ermini F, Stalder M, Schnell L, Sommer B, Jucker M, Staufenbiel M (2001) Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. AmJ Pathol 158, 63-73. (Pubitemid 32096472)